Cryptdin 4 inhibitors belong to a group of antimicrobial peptides known as cryptdins, which are primarily secreted by Paneth cells in the intestines. Cryptdin 4, like its counterparts, exhibits a potent ability to combat a variety of pathogens, including bacteria and fungi, thereby playing a crucial role in the innate immune response. Structurally, cryptdin 4 is characterized by its cationic charge and amphipathic properties, which facilitate its interaction with microbial membranes. This interaction is primarily through the formation of pores within the lipid bilayer of target microorganisms, leading to increased membrane permeability and eventual cell death. The ability of cryptdin 4 to disrupt microbial integrity highlights its importance in maintaining gut homeostasis and supporting the overall balance of the intestinal microbiota.
Inhibitors of cryptdin 4 function by interfering with its antimicrobial properties, often through mechanisms that involve competing with the peptide for membrane binding sites or altering its structural integrity. These inhibitors provide an interesting avenue for research into the mechanisms of action of antimicrobial peptides and the dynamics of host-pathogen interactions. The study of cryptdin 4 inhibitors not only enhances our understanding of microbial resistance mechanisms but also sheds light on the complex interplay between host-derived peptides and microbial populations in the gut. By elucidating how cryptdin 4 inhibitors impact the activity of this peptide, researchers can gain insights into the fundamental principles of innate immunity and the regulation of microbial communities within the gastrointestinal tract.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
Daptomycin, a cyclic lipopeptide antibiotic, directly inhibits Defa4 by disrupting bacterial cell membrane integrity. This inhibition influences the killing of cells from other organisms, providing a targeted approach to modulating antibacterial humoral responses. | ||||||
Polymyxin B Sulfate | 1405-20-5 | sc-3544 | 500 mg | $63.00 | 8 | |
Polymyxin B, a cationic polypeptide antibiotic, directly inhibits Defa4 by binding to bacterial membranes and disrupting their integrity. This inhibition influences the killing of cells from other organisms, providing a targeted approach to modulating antibacterial humoral responses. | ||||||
Bacitracin | 1405-87-4 | sc-252399 | 5 g | $89.00 | 1 | |
Bacitracin, a polypeptide antibiotic, directly inhibits Defa4 by interfering with bacterial cell wall synthesis. This inhibition influences the killing of cells from other organisms, providing a targeted approach to modulating antibacterial humoral responses. | ||||||
Novobiocin | 303-81-1 | sc-362034 sc-362034A | 5 mg 25 mg | $128.00 $380.00 | ||
Novobiocin, a coumarin antibiotic, directly inhibits Defa4 by targeting bacterial DNA gyrase, hindering DNA replication. This inhibition influences the killing of cells from other organisms, providing a targeted approach to modulating antibacterial humoral responses. | ||||||
Fusidic acid | 6990-06-3 | sc-215065 | 1 g | $292.00 | ||
Fusidic Acid, a steroid antibiotic, directly inhibits Defa4 by interfering with bacterial protein synthesis. This inhibition influences the killing of cells from other organisms, providing a targeted approach to modulating antibacterial humoral responses. | ||||||